Showing Results for
- Academic Journals (149)
Search Results
- 149
Academic Journals
- 149
-
From:Pharmacogenomics (Vol. 14, Issue 16) Peer-ReviewedAuthor(s): Miranda JL Zuurhout 1 , Susanne JH Vijverberg 1 2 , Jan AM Raaijmakers 1 , Leo Koenderman 2 , Dirkje S Postma 3 , Gerard H Koppelman 4 , Anke Hilse Maitland-van der Zee [*] 5 KEYWORDS : ADRB2; Arg16;...
-
From:British Medical Journal (Vol. 323, Issue 7326) Peer-ReviewedThe changes to the North of England evidence based guidelines on managing asthma in adults in primary care are not very great (see updated guidelines on bmj.com), but they are important and illustrate the need to keep...
-
From:Chest (Vol. 97, Issue 6) Peer-ReviewedNorepinephrine, an [[alpha].sub.1,2]-[beta].sub.1,2]-adrenergic agonist, seems to be an alternative to epinephrine, an [[alpha].sub.1,2]-[[beta].sub.1,2]-agonist, for restoration of spontaneous circulation in VF. We...
-
From:Chest (Vol. 102, Issue 2) Peer-ReviewedThe aim of this study was to investigate whether the administration of prednisone potentiates any of the acute biochemical and cardiovascular effects of high-dose inhaled [beta]-agonist drugs. These agents are known to...
-
From:Chest (Vol. 111, Issue 1) Peer-ReviewedStudy objective: We have previously described activation of the renin-angiotensin system (RAS) in acute severe asthma and have also reported activation of the RAS in normal subjects by single doses of nebulized...
-
From:British Medical Journal (Vol. 320, Issue 7226) Peer-ReviewedTwo doctors debate the use of corticosteroids as the initial treatment for asthma. Corticosteroids do not work in all patients and they have side effects. On the other hand, beta-agonists are effective bronchodilators...
-
From:Family Practice News (Vol. 29, Issue 11)SAN DIEGO -- Patients with moderate persistent asthma that is well controlled with low-dose inhaled corticosteroids cannot be switched to a long-acting [beta]-agonist without a clinically significant loss of asthma...
-
From:Journal of Respiratory Diseases (Vol. 26, Issue 6) Peer-ReviewedABSTRACT: [beta]-Agonists, administered by metered-dose inhaler or nebulizer, are still the mainstay of therapy for asthma exacerbations. A trial of a subcutaneous [beta]-agonist should be considered in patients who...
-
From:Chest (Vol. 97, Issue 1) Peer-ReviewedFor subjects with EIA participating in physical activities throughout the day, prolonged duration of protection is desirable. The purpose of this study was to determine whether in EIA a combination of the recommended...
-
From:Chest (Vol. 122, Issue 4) Peer-ReviewedObjectives: To determine the benefit of IV [[beta].sub.2]-agonists for severe acute asthma treated in the emergency department (ED). Methods: Randomized controlled trials were identified using EMBASE, MEDLINE, and...
-
From:Chest (Vol. 123, Issue 3) Peer-ReviewedAbbreviation: VASP = vasodilator-stimulated phosphoprotein The attachment and migration of airway epithelial cells is an important aspect of the repair of antigen-induced inflammatory injury in patients with asthma....
-
From:British Medical Journal (Vol. 326, Issue 7393) Peer-ReviewedA large epidemiological study has shown that short acting inhaled [beta] agonists do not increase the risk of myocardial infarction in patients with chronic obstructive pulmonary disease (COPD). More than 12 000...
-
From:Medical World News (Vol. 33, Issue 1)The use of beta agonists to treat asthma is under debate. Asthma is an inflammatory disease, and therefore needs anti-inflammatory drug therapy to treat the cause. Too often doctors give patients inhalers, thereby...
-
From:Patient Care (Vol. 40, Issue 8) Peer-ReviewedThe controversy over the proper place of long-acting beta-agonists (LABAs) in the arsenal of asthma medications has had a very long run. On one side are patients and their physicians who continue to use these drugs...
-
From:Science (Vol. 294, Issue 5545) Peer-ReviewedAlthough trafficking and degradation of several membrane proteins are regulated by ubiquitination catalyzed by E3 ubiquitin ligases, there has been little evidence connecting ubiquitination with regulation of mammalian...
-
From:Thorax (Vol. 57, Issue 12) Peer-Reviewed[S55] EXPRESSION OF TRANSFORMING GROWTH FACTOR ISOFORMS IN HUMAN AIRWAY SMOOTH MUSCLE AND NORMAL LUNG TISSUE B. Islam, D. Bradbury, L. Corbett, I. Soomro, J. Ronan, A. Knox. (1) Division of Respiratory Medicine; (2)...
-
From:British Medical Journal (Vol. 302, Issue 6786) Peer-ReviewedThere is much concern among physicians about the use of anti-asthmatic drugs called beta-2 agonists. At a recent meeting among physicians and pharmaceutical manufacturers, it was made clear that, despite serious...
-
From:Chest (Vol. 97, Issue 2) Peer-ReviewedEleven patients with severe COPD were examined to determine whether tolerance to [beta.sub.2]-agonists developed after long-term inhalation therapy with these agents. Before the study all patients were on regular...
-
From:Chest (Vol. 99, Issue 4) Peer-ReviewedPatients with chronic obstructive pulmonary disease (COPD) have difficulty breathing. One of the main goals in treating patients with COPD is to increase the size, or opening, of the airway passages in the lungs so that...
-
From:The Western Journal of Medicine (Vol. 163, Issue 4) Peer-ReviewedTWO LONG-ACTING [[Beta].sub.2]-agonists have been well studied, salmeterol (a derivative of albuterol), which became available in the United States in 1994, and formoterol, which is still under investigation. Both have...